Antithrombin III Deficiency
Showing 1 - 25 of >10,000
Antithrombin III Deficiency Trial in Brussel (observation)
Not yet recruiting
- Antithrombin III Deficiency
- observation
-
Brussel, BelgiumUZ Brussel
May 26, 2023
Antithrombin III Deficiency in Adult Patients With ECMO
Completed
- Antithrombin III Deficiency
- Extracorporeal Membrane Oxygenation Complication
- Antithrombin III
-
Istanbul, TurkeyIstanbul Dr.Siyami Ersek Thoracic and Cardiovascular Surgery Tra
May 22, 2022
Acquired Antithrombin Deficiency Trial (Human plasma derived antithrombin, Placebo)
Not yet recruiting
- Acquired Antithrombin Deficiency
- Human plasma derived antithrombin
- Placebo
- (no location specified)
Oct 17, 2023
Antithrombin III Deficiency Trial (Plasma-derived AT-III concentrate)
Active, not recruiting
- Antithrombin III Deficiency
- Plasma-derived AT-III concentrate
- (no location specified)
May 5, 2022
Congenital Antithrombin Deficiency Trial in Worldwide (Atenativ)
Recruiting
- Congenital Antithrombin Deficiency
-
Washington, District of Columbia
- +13 more
Sep 16, 2022
Antithrombin Deficiency in Patients of Intensive Care Unit
Completed
- Severe Cardiac Insufficiency
- Blood sample
-
Rennes, FranceCHU Rennes
Jun 3, 2021
Antithrombin III Treatment in Severe COVID-19 Infection
Active, not recruiting
- Covid19
- Antithrombin III
-
Innsbruck, Austria
- +5 more
Aug 1, 2022
Portal Vein Thrombosis, Cirrhosis, Liver Trial in Hershey (Antithrombin III, Placebo)
Withdrawn
- Portal Vein Thrombosis
- Cirrhosis, Liver
- Antithrombin III
- Placebo
-
Hershey, PennsylvaniaPenn State College of Medicine
Feb 23, 2022
Liver Transplantation and Antithrombin Trial in Seoul (Antithrombin III)
Completed
- Liver Transplantation and Antithrombin
- Antithrombin III
-
Seoul, Korea, Republic ofAsan Medical Center
May 30, 2021
ATIII Deficiency Trial in Durham (Anti-thrombin III, Placebo)
Completed
- ATIII Deficiency
- Anti-thrombin III
- Placebo
-
Durham, North CarolinaDuke University
Nov 21, 2019
Hepatic Veno-Occlusive Disease Trial in Seoul (Freeze-dried Concentrated Human Antithrombin ? 500 IU)
Active, not recruiting
- Hepatic Veno-Occlusive Disease
- Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU
-
Seoul, Chongno-gu, Korea, Republic ofSeoul National University Hospital
Mar 28, 2021
Heart Failure With Reduced Ejection Fraction, Iron Deficiency, Acute Heart Failure Trial in Beijing (Ferric derisomaltose,
Recruiting
- Heart Failure With Reduced Ejection Fraction
- +2 more
- Ferric derisomaltose
- Placebo
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Aug 5, 2023
Heart Failure With Preserved Ejection Fraction, Iron Deficiencies, Acute Heart Failure Trial in Beijing (Ferric derisomaltose,
Recruiting
- Heart Failure With Preserved Ejection Fraction
- +2 more
- Ferric derisomaltose
- Placebo
-
Beijing, Chaoyang District, ChinaChina-Japan Friendship Hospital
Aug 16, 2023
Heart Failure, Iron-deficiency, Heart Failure, Systolic Trial (Sucrosomial iron, Vitamin D, Ferric Carboxymaltose 50 MG/ML)
Not yet recruiting
- Heart Failure
- +5 more
- Sucrosomial iron
- +2 more
- (no location specified)
Jan 18, 2023
Patients With Periodontitis (Stage III)
Completed
- Vitamin D Deficiency
- Periodontitis
- taking a blood sample
-
Erzurum, None Selected, TurkeyAtaturk University
Jun 1, 2022
Mitochondrial DNA Depletion Syndrome 2 Myopathic Type, Thymidine Kinase 2 Deficiency Trial in New York (Thymidine)
Active, not recruiting
- Mitochondrial DNA Depletion Syndrome 2 Myopathic Type
- Thymidine Kinase 2 Deficiency
-
New York, New YorkColumbia University Irving Medical Center
Jul 28, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium
Recruiting
- Hereditary Angioedema
- +11 more
- PHA-022121 low dose
- +3 more
-
Birmingham, Alabama
- +7 more
Dec 5, 2022
Iron Deficiency, Anaemia in Children Trial (Ferric Derisomaltose)
Not yet recruiting
- Iron Deficiency, Anaemia in Children
- Ferric Derisomaltose
- (no location specified)
Mar 11, 2022
MPS (RaDiCo Cohort) (RaDiCo-MPS)
Recruiting
- Mucopolysaccharidosis I
- +7 more
-
Angers, France
- +22 more
Sep 12, 2023
Colorectal Cancer, Anemia, Iron-deficiency Trial (Iron(III)isomaltoside)
Not yet recruiting
- Colorectal Cancer
- +2 more
- (no location specified)
Jan 21, 2022
Orthodontic Appliance Complication Trial in Cairo (Intraoral protraction device, Extraoral protraction device)
Recruiting
- Orthodontic Appliance Complication
- Intraoral protraction device
- Extraoral protraction device
-
Cairo, Manial, EgyptFaculty of Oral and dental medicine - Cairo University
Apr 19, 2022
Mild and Moderate Iron-deficiency Anaemia Trial in Russian Federation (Ferrum Lek® (iron (III) hydroxide polymaltosate), 100 mg
Completed
- Mild and Moderate Iron-deficiency Anaemia
- Ferrum Lek® (iron (III) hydroxide polymaltosate), 100 mg chewable tablets (Lek d.d., Slovenia)
- MALTOFER® (iron (III) hydroxide polymaltosate), 100 mg chewable tablets (Vifor S.A., Switzerland)
-
Krasnogorsk, Russian Federation
- +17 more
Jun 18, 2021
Maxillary Deficiency, Maxillary Retrusion Trial in Cairo (Maxillary protraction)
Recruiting
- Maxillary Deficiency
- Maxillary Retrusion
- Maxillary protraction
-
Cairo, EgyptAl-azhar university- Faculty of Dental Medicine
Nov 27, 2021
Anterior Crossbite, Class III Malocclusion, Maxillary Deficiency Trial in Izmir (Face mask with hybrid-hyrax, Face mask with
Recruiting
- Anterior Crossbite
- +2 more
- Face mask with hybrid-hyrax
- Face mask with conventional bonded RME
-
İzmir, Çiğli, TurkeyIzmir Katip Celebi University,Faculty of Dentistry, Department o
Apr 27, 2021
Iron-deficiency, Colorectal Cancer Trial in Køge, Slagelse, Randers (Iron(III)isomaltoside, Placebo)
Not yet recruiting
- Iron-deficiency
- Colorectal Cancer
- Iron(III)isomaltoside
- Placebo
-
Køge, Danmark, Denmark
- +2 more
Feb 14, 2022